Andreessen Horowitz Brings On Julie Yoo As General Partner To Focus On Bio Fund

By Amit Chowdhry ● October 17, 2019
  • Andreessen Horowitz recently announced it has hired Julie Yoo as a general partner to make investments from its bio fund

Silicon Valley-based venture capital firm Andreessen Horowitz (a16z) recently announced it hired Julie Yoo as a general partner to make investments from its bio fund. The bio fund had closed $450 million in 2017. Prior to joining a16z, Yoo was the co-founder and chief product officer of healthcare provider matching company Kyruus.

According to TechCrunch, Yoo is a16z’s seventeenth general partner following the hiring of David George and Anish Acharya. And Yoo became the fourth female general partner at the firm. Kathryn Haun was a16z’s first female partner and she is overseeing crypto investments with Chris Dixon. Connie Chan and Angela Strange were promoted internally to general partners.

At a16z, Yoo will be working with Vijay Pande and Jorge Conde within the biotech team. The three of them will be overseeing technology like life sciences, synthetic bio, and other health technologies.


“As Julie recognized when founding Kyruus, our healthcare system could use an upgrade. We’re in the midst of a major tectonic shift in this $3 trillion sector: technology is on the verge of transforming how we access, pay for, and even deliver healthcare; software is eating care delivery. As one of the bold entrepreneurs helping to catalyze the industry herself, Julie has a deep understanding of how to support founders on their journeys through this high-stakes, high-impact world,” wrote Conde in a blog post. “She has fought the boardroom battles, endured the long sales cycles, and has orchestrated complex integrations into legacy infrastructure. Her network runs deep, from decision-makers at leading health systems and insurers to the next-generation entrepreneurs building the next new thing. And she’s known across the industry as an inexhaustible source of energy and enthusiasm.”